Ex vivo lentiviral gene therapy for mucopolysaccharidosis type IVA

被引:0
|
作者
Celik, Betul [1 ]
Rintz, Estera [2 ]
Nidhi, Fnu [3 ]
Khan, Shaukat [4 ]
Tomatsu, Shunji [4 ]
机构
[1] Univ Delaware, Wilmington, DE USA
[2] Univ Gdansk, Gdansk, Poland
[3] Univ Delaware, Newark, DE USA
[4] Neumors Childrens Hosp, Wilmington, DE USA
关键词
D O I
10.1016/j.ymgme.2023.107789
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
50
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency
    Kohn, D. B.
    Booth, C.
    Shaw, K. L.
    Xu-Bayford, J.
    Garabedian, E.
    Trevisan, V.
    Carbonaro-Sarracino, D. A.
    Soni, K.
    Terrazas, D.
    Snell, K.
    Ikeda, A.
    Leon-Rico, D.
    Moore, T. B.
    Buckland, K. F.
    Shah, A. J.
    Gilmour, K. C.
    De Oliveira, S.
    Rivat, C.
    Crooks, G. M.
    Izotova, N.
    Tse, J.
    Adams, S.
    Shupien, S.
    Ricketts, H.
    Davila, A.
    Uzowuru, C.
    Icreverzi, A.
    Barman, P.
    Fernandez, B. Campo
    Hollis, R. P.
    Coronel, M.
    Yu, A.
    Chun, K. M.
    Casas, C. E.
    Zhang, R.
    Arduini, S.
    Lynn, F.
    Kudari, M.
    Spezzi, A.
    Zahn, M.
    Heimke, R.
    Labik, I.
    Parrott, R.
    Buckley, R. H.
    Reeves, L.
    Cornetta, K.
    Sokolic, R.
    Hershfield, M.
    Schmidt, M.
    Candotti, F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (21): : 2002 - 2013
  • [22] Regulatory challenges in development of lentiviral ex vivo gene therapy products
    Eggimann, A-V
    HUMAN GENE THERAPY, 2013, 24 (12) : A6 - A6
  • [23] Regulatory Challenges in Development of Lentiviral Ex Vivo Gene Therapy Products
    Eggimann, Anne-Virginie L.
    Siggers, Keri
    Dittman, Jennifer
    MOLECULAR THERAPY, 2014, 22 : S214 - S214
  • [24] Ex Vivo Lentiviral Gene Therapy as a Cure for Murine Pompe Disease
    Stok, Merel
    de Boer, Helen
    Huston, Marshall W.
    Jacobs, Edwin H.
    Roovers, Onno
    Jahr, Holger
    Duncker, Dirk J.
    Visser, Trudi P.
    van der Ploeg, Ans T.
    Reuser, Arnold J. J.
    van Til, Nico P.
    Wagemaker, Gerard
    MOLECULAR THERAPY, 2013, 21 : S105 - S105
  • [25] Development of Lentiviral Mediated Stem Cell Gene Therapy for Mucopolysaccharidosis Type IIIA
    Ellison, Stuart
    Sergijenko, Ana
    Langford-Smith, Alex
    Langford-Smith, Kia
    Wraith, Ed
    Wynn, Rob
    Wilkinson, Fiona
    Bigger, Brian
    MOLECULAR THERAPY, 2014, 22 : S8 - S8
  • [26] A MODEL OF EX-VIVO LYMPHOCYTE GENE-THERAPY FOR HUNTER SYNDROME, MUCOPOLYSACCHARIDOSIS TYPE-II
    BRAUN, SE
    JONSSON, JJ
    ARONOVICH, EL
    MCIVOR, RS
    WHITLEY, CB
    AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 409 - 409
  • [27] Ex vivo gene therapy improves the accumulation of glycosaminoglycans in brain from murine model of mucopolysaccharidosis type II
    Wakabayashi, Taichi
    Shimada, Yohta
    Higuchi, Takashi
    Kobayashi, Hiroshi
    Ida, Hiroyuki
    Ohashi, Toya
    GLYCOBIOLOGY, 2014, 24 (11) : 1214 - 1214
  • [28] DEVELOPMENT OF LENTIVIRAL VECTORS FOR EX VIVO REGIONAL GENE THERAPY FOR SPINAL FUSION
    Ge, P. S.
    Van Handel, B. J.
    Mikkola, H. K.
    Wang, J. C.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 148 - 149
  • [29] Autologous Ex Vivo Lentiviral Gene Therapy for the Treatment of ADA-SCID
    Booth, Claire
    Kohn, Don B.
    Shaw, Kit L.
    Xu-Bayford, Jinhua
    Garabedian, Elizabeth
    Trevisan, Valentina
    Carbonaro-Sarracino, Denise A.
    Soni, Kajal
    Terrazas, Dayna
    Snell, Katie
    Leon-Rico, Diego
    Buckland, Karen
    Gilmour, Kimberly
    De Oliveira, Satiro
    Rivat, Christine
    Izotova, Natalia
    Adams, Stuart
    Ricketts, Hilory
    Davila, Alejandra
    Uzowuru, Chilenwa
    Fernandez, Beatriz Campo
    Hollis, Roger P.
    Coronel, Maritess
    Zhang, Ruixue
    Arduini, Serena
    Lynn, Frances
    Kudari, Mahesh
    Spezzi, Andrea
    Zhan, Marco
    Heimke, Rene
    Labik, Ivan
    Cornetta, Kenneth
    Sokolic, Robert
    Hershfield, Michael
    Schmidt, Manfred
    Candotti, Fabio
    Malech, Harry L.
    Thrasher, Adrian J.
    Gaspar, H. Bobby
    MOLECULAR THERAPY, 2021, 29 (04) : 20 - 20
  • [30] Gene therapy for a mucopolysaccharidosis type I murine model with lentiviral-IDUA vector
    Di Domenico, C
    Villani, GRD
    Di Napoli, D
    Reyero, EGY
    Lombardo, A
    Naldini, L
    Di Natale, P
    HUMAN GENE THERAPY, 2005, 16 (01) : 81 - 90